The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)

Aim: Prostate artery embolization (PAE) is a non invasive modality for the treatment of benign prostate hypertrophy (BPH) related lower urinary tract symptoms (LUTS). As a relatively new procedure, data determining the clinical success is somehow scarce. In the present article we examine the current...

Full description

Bibliographic Details
Main Author: Konstantinos Stamatiou
Format: Article
Language:English
Published: PAGEPress Publications 2018-03-01
Series:Archivio Italiano di Urologia e Andrologia
Subjects:
Online Access:http://www.pagepressjournals.org/index.php/aiua/article/view/7067
id doaj-7a435038d9494fb89bd5d72010dbaf60
record_format Article
spelling doaj-7a435038d9494fb89bd5d72010dbaf602020-11-25T02:05:28ZengPAGEPress PublicationsArchivio Italiano di Urologia e Andrologia1124-35622282-41972018-03-01901404310.4081/aiua.2018.1.405643The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)Konstantinos Stamatiou0Urology Department, Tzaneio Hospital, PiraeusAim: Prostate artery embolization (PAE) is a non invasive modality for the treatment of benign prostate hypertrophy (BPH) related lower urinary tract symptoms (LUTS). As a relatively new procedure, data determining the clinical success is somehow scarce. In the present article we examine the current clinical outcome measures in order to identify the most accurate. Results: Current imaging outcome measures are consistent with clinical ones only in the group of patients with adenomatous- dominant BPH while are inconsistent in patients with small sized adenomas. Conclusions: Additional studies and/or evaluation tools are needed in order to provide accurate evaluation of clinical success in the subgroup of patients with non- adenomatous-dominant BPH while they may inspire new options and novel techniques for both BPH treatment and treatment-follow up.http://www.pagepressjournals.org/index.php/aiua/article/view/7067Benign prostatic hyperplasiaLower urinary tract symptomsProstate artery embolization
collection DOAJ
language English
format Article
sources DOAJ
author Konstantinos Stamatiou
spellingShingle Konstantinos Stamatiou
The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)
Archivio Italiano di Urologia e Andrologia
Benign prostatic hyperplasia
Lower urinary tract symptoms
Prostate artery embolization
author_facet Konstantinos Stamatiou
author_sort Konstantinos Stamatiou
title The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)
title_short The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)
title_full The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)
title_fullStr The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)
title_full_unstemmed The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)
title_sort impact of prostate artery embolization (pae) on the the physical history and pathophysiology of benign prostatic hyperplasia (bph)
publisher PAGEPress Publications
series Archivio Italiano di Urologia e Andrologia
issn 1124-3562
2282-4197
publishDate 2018-03-01
description Aim: Prostate artery embolization (PAE) is a non invasive modality for the treatment of benign prostate hypertrophy (BPH) related lower urinary tract symptoms (LUTS). As a relatively new procedure, data determining the clinical success is somehow scarce. In the present article we examine the current clinical outcome measures in order to identify the most accurate. Results: Current imaging outcome measures are consistent with clinical ones only in the group of patients with adenomatous- dominant BPH while are inconsistent in patients with small sized adenomas. Conclusions: Additional studies and/or evaluation tools are needed in order to provide accurate evaluation of clinical success in the subgroup of patients with non- adenomatous-dominant BPH while they may inspire new options and novel techniques for both BPH treatment and treatment-follow up.
topic Benign prostatic hyperplasia
Lower urinary tract symptoms
Prostate artery embolization
url http://www.pagepressjournals.org/index.php/aiua/article/view/7067
work_keys_str_mv AT konstantinosstamatiou theimpactofprostatearteryembolizationpaeonthethephysicalhistoryandpathophysiologyofbenignprostatichyperplasiabph
AT konstantinosstamatiou impactofprostatearteryembolizationpaeonthethephysicalhistoryandpathophysiologyofbenignprostatichyperplasiabph
_version_ 1724937745322737664